How We Work
We work with donors in every stage of their giving journey, from brand new philanthropists to seasoned leaders of effective giving. Depending on your particular needs, we can introduce you to experts on the world’s largest and most neglected issues, bring you into our curated learning sessions on the principles of effective giving, or simply meet you in the trenches and share our current grant opportunities and the reasoning behind them. Everything we do is always completely free of charge or commission.
Today, anyone can order DNA from private companies, and it will only become faster and cheaper to do so in the coming years. Unfortunately, we don’t yet have a safe and efficient way to screen for DNA that could be used to manufacture a bioweapon. Current methods involve comparing potentially-dangerous sequences to a database of harmful sequences—effectively creating a public recipe book for bioweapons. SecureDNA aims to avert this danger. Scientists from MIT and Tsinghua University are creating technology that can quickly, automatically, and securely screen incoming DNA synthesis requests for potential threats. If successful, this project could make it far more difficult for malicious actors to create and release bioweapons, and could avert future pandemics.
The Organisation for Economic Cooperation and Development (OECD) is a leading forum for international coordination on expert policy advice and best governance practices. Their work supports 38 member countries—including the US and the EU—and non-member partners, including China. Their data analysis underpins work by the UN and the G20. The OECD is especially consequential for multilateral cooperation on artificial intelligence. They host the dominant international institution for AI governance, the AI Policy Observatory. We have an ongoing partnership with the OECD to support their work on existential risk policy across several directorates, including the Strategic Foresight Unit, the High-Level Risk Forum, the AI Policy Observatory, and the Secretariat on Bio-, Nano-, and Converging Technologies.